Imidazopyridine derivatives as kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S118000, C546S141000, C544S127000, C514S234200, C514S307000

Reexamination Certificate

active

07348339

ABSTRACT:
A compound of the formulaand physiologically acceptable salts and or N-oxides thereof wherein,X1is N or CR3; X2is N or CR4; X3is N or CR5; X4is N or CR6.with the proviso that at least one but not more than two of X1, X2, X3and X4represents N.R1is a 5-, or 6-membered heterocyclic group selected from group a, b, c or dwherein X5is a group selected from N or CR7and X6is a group selected from O, S or NR8; X7and X8which may be the same or different is a group selected from N or CR9; X9is a group selected from O, S or NR8and X10is N or CR10; X11, X12and X13may be the same or different and selected from a group N or CR11; processes for their preparation, pharmaceutical compositions containing them and their use in medicine.

REFERENCES:
patent: 2007/0004771 (2007-01-01), Lee et al.
patent: 37 22 992 (1989-01-01), None
patent: 3722992 (1989-01-01), None
patent: 1 034 793 (2000-09-01), None
patent: 01 57018 (2001-08-01), None
Weber et al., Pharmacology, 2001, vol. 63, pp. 129-133.
Persidsky et al., Journal of Neuroimmunology, 2001, vol. 114, pp. 57-68.
Nawwar, Galal A.M., et al: “Studies on 2-substituted methylazoles: the preparation and reactions of 2-cyanomethylimidazo′4,5bipyridine” Anles de Quimica (1993), 89(3), 375-8, XP009012073, compound 9.
Kumar, Shiv et al: “Adenine photodimerization in deoxyadenylate sequences: elucidation of th mechanism through structural studies of a major d(ApA) photoproduct” Nucleic Acids Research (1991), 19(11), 2841-7, XP001147581, compound 4.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imidazopyridine derivatives as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazopyridine derivatives as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridine derivatives as kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3970834

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.